Picture of Freeline Therapeutics Holdings logo

FRLN Freeline Therapeutics Holdings Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Freeline Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:PROSPECTUSPROSPECTUS20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments16.173.723011847.3
Net Total Accounts Receivable
Net Total Receivables8.9911.516.12.211.23
Prepaid Expenses
Total Other Current Assets
Total Current Assets26.18925812867.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment5.737.278.619.9115
Net Intangible Assets
Other Long Term Assets
Total Assets32.197.426914186.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities9.1612.418.820.731
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities9.1612.418.820.734.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity238525012052.4
Total Liabilities & Shareholders' Equity32.197.426914186.6
Total Common Shares Outstanding